"Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company"

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

At the World Drug Safety Congress Americas 2014 Susan Duke, GSK, gave a presentation on "Implementing benefit-risk thinking and qualification into the culture and processes of a large pharmaceutical company."

Download and learn:

Benefit-Risk thinking and quantitative evaluation at GSK
How it began
Where we are now
Keeping it simple (unless it’s complex)
What are the right questions?
Where is our industry as a whole on quantitative Benefit-Risk evaluation?

"Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company"

information we require

please check before submitting